期刊文献+

糖尿病多支冠状动脉病变患者不同血管重建疗效的比较 被引量:11

Evaluation of different revascularization strategies in diabetic patients with multivessel abnormalities
原文传递
导出
摘要 目的:评价对糖尿病多支冠状动脉病变患者的裸支架(BMS)置入、药物洗脱支架(DES)置入和冠状动脉搭桥手术(CABG)3种不同血管重建的疗效。方法:选择接受血管重建治疗的糖尿病伴多支冠状动脉病变患者427例,比较其BMS、DES和CABG不同治疗方法的疗效和随访2年的临床结果。结果:BMS、DES和CABG3组间住院时期的不良心脑血管事件(MACCE)发生率比较,差异均无统计学意义。2年随访结果中,BMS组、DES组再次血管重建率分别为17.6%、10.4%,均显著高于CABG组的1.9%(P<0.01);BMS组的总MACCE发生率为23.1%,显著高于CABG组的10.7%(P<0.01),而DES的总MACCE发生率与CABG组相比差异无统计学意义。结论:糖尿病多支血管病变患者置入BMS后再次血管重建率和总MACCE发生率显著高于CABG,而DES的中期临床疗效并不逊于CABG。 Objective:The study aims to evaluate three revascularization strategies, including bare metal stent (BMS) implantation, drug eluting stent (DES) implantation and coronary artery bypass surgery (CABG) in diabetic patients with multivessel abnormalities. Method: Four hundred and twenty-seven patients with diabetes and multivessel abnormalities who underwent the revascularization in our institution were enrolled to compare their clinical outcomes during hospitalization and 2-year followup among BMS, DES and CABG groups. Result: No statistical differences are found in the rate of in-hospital major adverse cardiac and cerebrovascular events (MACCE) among the BMS, DES and CABG groups. During 2-year follow up, the rate of repeat revascularization in BMS group was 17.6% and MACCE was 23. 1%, which were much higher than those of DES and CABG groups. The risk of repeat revacularization in BMS group was 16. 858 (95% CI 4. 079-69. 677, P〈0.0l) times that of the CABGgroup, and the risk of MACCE is 3. 484 (95% CI 1.565-7.753, P〈0.01) times that of the CABG group. The 2-year followup event-free survival of BMS group was much lower than that of CABG group. In the DES group, the rate of repeat revascularization was 10.4%, which was much lower than that of the BMS group but still higher than that of the CABG group. No differences were found in the rates of 2-year followup MACCE and event-free survival between DES and CABG groups. Conclusion: The intermediate clinical outcomes of drug eluting stent implanation was not inferior to coronary bypass surgery for diabetic patients with multivessel diseases.
出处 《临床心血管病杂志》 CAS CSCD 北大核心 2007年第7期519-522,共4页 Journal of Clinical Cardiology
基金 国家重点基础研究发展规划基金资助项目(973计划)(2003CB517103)
关键词 糖尿病 冠状动脉疾病 支架 冠状动脉旁路移植术 Diabetes Coronary disease Stent Coronary artery bypass surgery
  • 相关文献

参考文献13

  • 1MATHEW V,GERSH B J,WILLIAMS B A,et al.Outcomes in patients with diabetes mellitus undergoing percutaneous coronary intervention in the current era:a report from the Prevention of RES tenosis with Tranilast and its Outcomes(PRESTO) trial[J].Circulation,2004,109:476-480. 被引量:1
  • 2KUNTZ R E.Importance of considering atherosclerosis progression when choosing a coronary revascularization strategy:the diabetes-percutaneous transluminal coronary angioplasty dilemma[J].Circulation,1999,99:847-851. 被引量:1
  • 3FRYE R L,BROOKS M M,NESTO R W.Gap between clinical trials and clinical practice:lessons from the Bypass Angioplasty Revascularization Investigation(BARI)[J].Circulation,2003,107:1837-1839. 被引量:1
  • 4MOUSSA I,LEON M B,BAIM D S,et al.Impact of sirolimus-eluting stents on outcome in diabetic patients:a SIRIUS(SIRolImUS-coated Bx Velocity balloonexpandable stent in the treatment of patients with de novo coronary artery lesions) substudy[J].Circulation,2004,109:2273-2278. 被引量:1
  • 5HERMILLER J B,RAIZNER A,CANNON L,et al.Outcomes with the polymer-based paclitaxel-eluting TAXUS stent in patients with diabetes mellitus:the TAXUS-IV trial[J].J Am Coll Cardiol,2005,45:1172-1179. 被引量:1
  • 6BARRETT-CONNOR E.Does hyperglycemia really cause coronary heart disease?[J].Diabetes Care,1997,20:1620-1623. 被引量:1
  • 7KIP K E,FAXON D P,DETRE K M,et al.Coronary angioplasty in diabetic patients.The national heart,lung,and blood institute percutaneous transluminal coronary angioplasty registry[J].Circulation,1996,94:1818-1825. 被引量:1
  • 8ROZENMAN Y,SAPOZNIKOV D,MOSSERI M,et al.Long-term angiographic follow-up of coronary balloon angioplasty in patients with diabetes mellitus:a clue to the explanation of the results of the BARI study.Balloon angioplasty revascularization investigation[J].J Am Coll Cardiol,1997,30:1420-1425. 被引量:1
  • 9SOBEL B E.Altered fibrinolysis and platelet function in the development of vascular complications of diabetes[J].Curr Opin Endocrinol Diabetes,1996,3:355-360. 被引量:1
  • 10SHENADEH A,REGAN T J.Cardiac consequence of diabetes mellitus[J].Clin Cardiol,1995,18:301-305. 被引量:1

二级参考文献21

  • 1Fukuda D,Shimada K,Tanaka A,et al.Circulating monocytes and in-stent neointima after coronary stent implantation.J Am Coll Cardiol ,2004,43:18-23. 被引量:1
  • 2Wilensky R L,March K L,Gradus-Pizlo I,et al.Vascular injury,repair,and restenosis after percu taneous transluminal angioplasty in the atherosclerotic rabbit.Circulation,1995,92:2995-3005. 被引量:1
  • 3Kornowski R, Hong M K, Tio F O, et al.In-stent restenosis:Contributions of inflammatory responses and arterial injury to neointimal hyperplasia.J Am Coll Cardiol,1998,31:224-230. 被引量:1
  • 4Shi Y,O′Brien J E,Fard A,et al.Adventitial myofibroblasts contribute to neointimal formation in injured porcine coronary arteries.Circulation,1996,94:1655-1664. 被引量:1
  • 5Regar E,Serruys P W,Bode C,et al.Angiographic findings of the multicenter randomized study with the sirolimus-eluting Bx Velocity balloon-expandable stent(RAVEL):Sirolimus-eluting stents inhibit restenosis irrespective of the vessel size.Circulation,2002,106:1949-1956. 被引量:1
  • 6Holmes D R Jr,Leon M B,Moses J W,et al.One year follow-up of the SIRIUS study:A randomized study with the sirolimus-eluting Bx VelocityTM in the treatment of patients with de novo native coronary artery lesions.J Am Coll Cardiol,2003,41(Suppl A):32A. 被引量:1
  • 7Stone G W, Ellis S G,Cox D A,et al.A polymer-based,paclitaxel-eluting stent in patients with coronary artery disease.N Engl J Med ,2004,350:221-231. 被引量:1
  • 8Kataoka T, Grube E, Honda Y,et al.7-hexanoyltaxol-eluting stent for prevention of neointimal growth:An intravascular ultrasound analysis from the study to compare restenosis rate between quest and quads-QP2(SCORE).Circulation,2002,106:1788-1793. 被引量:1
  • 9Colombo A, Louvard Y, Raghu C, et al. Sirolimus eluting stent in bifurcation lesions:six months angiographic result according to the inplantation technique.J Am Coll Cardiol,2003,41:53A. 被引量:1
  • 10Airoldi F,Spanos V,Stankovic G,et al.Bifurcational coronary artery lesion treatment with rapa- micine-eluting stents:results from a single center experience.J Am Coll Cardiol ,2003,41:53A. 被引量:1

共引文献4

同被引文献75

引证文献11

二级引证文献37

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部